Trial site
Alliance for Multispecialty Research LLC
- 3running trials
- 8closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Obesity3 trials
- Fatty liver disease (MASLD/MASH)2 trials
- Type 2 diabetes2 trials
- Coeliac disease1 trial
- Diabetic neuropathy1 trial
- Gout1 trial
- Graves' disease1 trial
- Psoriasis1 trial
- Psoriatic arthritis1 trial
- Rheumatoid arthritis1 trial
- Phase
- Phase 36 trials
- Phase 24 trials
- Phase 41 trial
- Status
- Completed8 trials
- Recruiting2 trials
- Active, not recruiting1 trial
- Lead sponsor
- Eli Lilly and Company4 trials
- Amgen2 trials
- Achieve Life Sciences1 trial
- argenx1 trial
- Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Graves' disease1 recruiting
- Obesity1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Completed
Safety Study of Cytisinicline in Adult Combustible and/or E-cigarette Smokers
Completed
A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease
Completed
A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain
Completed
Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients
Completed
Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)
Completed
A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)
Completed
A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis
Site data: ClinicalTrials.govUpdated 15 Nov 2026